Skip to content

Drug Regulatory Authority of Pakistan

Ministry of National Health Services, Regulations & Coordination

اردو | English

facebook
twitter
envelope

Menu

About Us
Therapeutic Goods
Safety Info
News & Updates
Publications
E-Services
Medicine Availability
Support

Home > News & Updates > Regulatory Updates > Clinical Trials > Conduct Of Clinical Trials Guidelines (v2.0) Stake holders are invited for comments to be submitted within 15 days to email: drap.pharmacy@gmail.com

Conduct Of Clinical Trials Guidelines (v2.0) Stake holders are invited for comments to be submitted within 15 days to email: drap.pharmacy@gmail.com

Murtaza Awan Clinical Trials September 2, 2021December 30, 2021Pharmacy Services

This is the second edition of these guidelines. The first edition was published on 08th November, 2019.

PDF File Download

Share this:

Twitter
Facebook

← List Of Required Sops At BA/BE Studies Center
Notification F.No.8-3/2019-H&OTC →

Drugs
Medical Devices
Alternative Medicines
Controlled Substances
Licensing and Inspections
Clinical Trials
Pharmacovigilance
Advertisements
General

Quick Navigation

Quick Navigation

Archives

Archives

Drug Regulatory Authority of Pakistan

Islamabad | Karachi | Lahore | Peshawar | Quetta
Phone: 0800-03727 (Mon to Fri 08:30AM to 04:30PM)
Website: www.dra.gov.pk

Developed by MIS Division. All rights reserved to Drug Regulatory Authority of Pakistan

Contact Us
Report a Problem